Sang-Jae Kim
Director Ejecutivo en SAMSUNG PHARM. CO., LTD. .
Fortuna: 70 M $ al 31/05/2024
Perfil
Sang-Jae Kim is currently the Co-Chief Executive Officer & Director at SAMSUNG PHARMACEUTICAL Co., Ltd.
and Gemvaxlink Co., Ltd.
He is also the Chief Executive Officer at Gem & Co., KAEL-GemVax Co., Ltd., Gemvax USA, Inc., Teloid, Inc., and a Director at Gemvax.
AS and Flask Co., Ltd.
In the past, he held positions as the Co-Chief Executive Officer & Director at Flask Co., Ltd.
and GemVax & KAEL Co., Ltd.
He was also the Chief Executive Officer at Maxbro Co., Ltd., Korea Stem Cell Bank Co., Ltd., and Kael Co., Ltd.
Additionally, he served as a Director at NovaHep AB.
Dr. Kim completed his undergraduate, graduate, and doctorate degrees at Hanyang University.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
GEMVAX & KAEL CO LTD
21.72% | 18/06/2024 | 8 686 756 ( 21.72% ) | 69 M $ | 31/05/2024 |
FLASK CO., LTD.
1.14% | 14/02/2024 | 1 500 000 ( 1.14% ) | 879 105 $ | 31/03/2024 |
Cargos activos de Sang-Jae Kim
| Empresas | Cargo | Inicio |
|---|---|---|
| SAMSUNG PHARM. CO., LTD. | Director Ejecutivo | 26/06/2015 |
| GEMVAXLINK CO., LTD. | Director Ejecutivo | 14/03/2017 |
| FLASK CO., LTD. | Director/Miembro de la Junta | - |
KAEL-GemVax Co., Ltd.
 KAEL-GemVax Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of GemVax & KAEL Co., Ltd., KAEL-GemVax Co., Ltd. manufactures bio-pharmaceutical products. The company is based in Seongnam, South Korea. The CEOs of the South Korean company are Gyeong Hee Kim, Sang-Jae Kim, Magnus Moliteus. | Director Ejecutivo | 06/09/2011 |
Gem & Co. /KR/
 Gem & Co. /KR/ Investment ManagersFinance Gem & Co. /KR/ engages in the provision of financial consulting and trading services. The company was founded on September 9, 2004 and is headquartered in Seongnam, South Korea. | Director Ejecutivo | - |
Gemvax AS
 Gemvax AS Pharmaceuticals: MajorHealth Technology Part of GemVax & KAEL Co., Ltd., Gemvax AS is a Norwegian peptide-based drug development company that focuses on researching and developing treatments for Alzheimer's disease and prostate hyperplasia. The company is based in Porsgrunn, Norway. The company also develops and sell products such as CA filters and provide investment information. The company was founded by Mona Elisabeth Møller. Gemvax was acquired by VaxOnco, Inc. from Pharmexa A/S on October 30, 2008. | Director/Miembro de la Junta | - |
| Gemvax USA, Inc. | Director Ejecutivo | - |
| Teloid, Inc. | Director Ejecutivo | - |
Antiguos cargos conocidos de Sang-Jae Kim.
| Empresas | Cargo | Fin |
|---|---|---|
| GEMVAX&KAEL CO.,LTD. | Director Ejecutivo | 01/01/2024 |
| ░░░░░ ░░░░ ░░░░ | ░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░ ░░░░ | ░░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░ | ░░░░░░░░░░░░░░░░ ░░ ░░ ░░░░░ | - |
| ░░░░░ ░░░░ ░░░░ ░░░░ ░░░░ ░░░░ | ░░░░░░░░ ░░░░░░░░░ | - |
Formación de Sang-Jae Kim.
| Hanyang University | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 4 |
|---|---|
| GEMVAX&KAEL CO.,LTD. | Producer Manufacturing |
| FLASK CO., LTD. | Electronic Technology |
| SAMSUNG PHARM. CO., LTD. | Health Technology |
| GEMVAXLINK CO., LTD. | Retail Trade |
| Empresas privadas | 9 |
|---|---|
Maxbro Co., Ltd.
 Maxbro Co., Ltd. Electronic Production EquipmentElectronic Technology Maxbro Co., Ltd. engages in plastic products and education. Its business includes wibro(egg), kid's education, copper plating, and overseas business. Wibro business are for WiMax Wi-Fi router which helps Wi-Fi devices to access to WiMax net. Kid's education is based on European education using kinder schule. Copper plating includes cable industry which is mainly used in fibre optic cable lines in supplying power to various power line and data. Overseas business are petrochemicals and non-ferrous metals. The company was founded in March 2006 and is headquartered in Suwon, South Korea. | Electronic Technology |
Kael Co., Ltd.
 Kael Co., Ltd. Chemicals: SpecialtyProcess Industries Kael Co. Ltd. engages in production of Fundamental Products, Semi-Conductor & Display, Bio Business Field and Environment. The company's products are Coating Resin, CA Filter, Gas Scrubber & Resin, KAEL-GemVax, KSCB, Adsorbent Tower, Positive Pressure Facility and so on. It was founded on March 10, 1998 and is headquartered in Daejeon, South Korea. | Process Industries |
KAEL-GemVax Co., Ltd.
KAEL-GemVax Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of GemVax & KAEL Co., Ltd., KAEL-GemVax Co., Ltd. manufactures bio-pharmaceutical products. The company is based in Seongnam, South Korea. The CEOs of the South Korean company are Gyeong Hee Kim, Sang-Jae Kim, Magnus Moliteus. | Health Technology |
Korea Stem Cell Bank Co., Ltd.
 Korea Stem Cell Bank Co., Ltd. BiotechnologyHealth Technology Korea Stem Cell Bank Co., Ltd. develops stem cell storage and treatment technology solutions. It also engages in the research and development of stem cell therapies to treat various diseases, including cancers, chronic, and incurable diseases. The company was founded on December 20, 2005 and is headquartered in Seongnam-si, South Korea. | Health Technology |
Gem & Co. /KR/
Gem & Co. /KR/ Investment ManagersFinance Gem & Co. /KR/ engages in the provision of financial consulting and trading services. The company was founded on September 9, 2004 and is headquartered in Seongnam, South Korea. | Finance |
Gemvax AS
Gemvax AS Pharmaceuticals: MajorHealth Technology Part of GemVax & KAEL Co., Ltd., Gemvax AS is a Norwegian peptide-based drug development company that focuses on researching and developing treatments for Alzheimer's disease and prostate hyperplasia. The company is based in Porsgrunn, Norway. The company also develops and sell products such as CA filters and provide investment information. The company was founded by Mona Elisabeth Møller. Gemvax was acquired by VaxOnco, Inc. from Pharmexa A/S on October 30, 2008. | Health Technology |
| Gemvax USA, Inc. | |
NovaHep AB
 NovaHep AB Miscellaneous Commercial ServicesCommercial Services NovaHep AB provides stem-cell research for gene therapy of liver diseases. Its main area of focus is the development of biological, individualised blood vessels that can be used to replace non-functioning blood vessels in patients with different types of vascular disease. The company was founded by Suchitra Sumitran-Holgersson and Jan Anders Holgersson in 2005 and is headquartered in Gothenburg, Sweden. | Commercial Services |
| Teloid, Inc. |
- Bolsa de valores
- Insiders
- Sang-Jae Kim
